Table 1 Degree of inhibition of nHAP treatment on human cancer cells and normal cells. The cancer cells (MGC-803, Os-732 and Bel-7402) and normal cells (L-02, MRC-5 and HaCaT) were treated with low (0.14 g L⁻¹) and high (0.56 g L⁻¹) concentrations of nHAP for 3 days. The data represent the average of 3–5 measurements

From: Different Inhibitory Effect and Mechanism of Hydroxyapatite Nanoparticles on Normal Cells and Cancer Cells In Vitro and In Vivo